tiprankstipranks
Yubo International Biotech (YBGJ)
OTHER OTC:YBGJ
US Market

Yubo International Biotech (YBGJ) Income Statement

6 Followers

Yubo International Biotech Income Statement

Last quarter (Q ), Yubo International Biotech's total revenue was $66.52K, a decrease of -79.98% from the same quarter last year. In Q, Yubo International Biotech's net income was $103.61K. See Yubo International Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20
Total Revenue
$ 104.28K$ 104.28K$ 1.24M$ 1.35M
Cost of Revenue
$ 51.63K$ 51.63K$ 423.73K$ 114.27K
Gross Profit
$ 52.65K$ 52.65K$ 820.65K$ 1.24M
Operating Expense
$ 1.26M$ 1.26M$ 2.36M$ 1.95M
Operating Income
$ -1.21M$ -1.21M$ -1.54M$ -711.80K
Net Non Operating Interest Income Expense
$ 229.00$ 229.00$ 427.00$ -3.00
Other Income Expense
----
Pretax Income
$ -1.20M$ -1.20M$ -1.54M$ -711.80K
Tax Provision
-$ 0.00$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
----
Net Income Common Stockholders
$ -1.20M$ -1.20M$ -1.54M$ -711.80K
Basic EPS
$ >-0.01$ -0.01-$ >-0.01
Diluted EPS
$ >-0.01$ -0.01-$ >-0.01
Basic Average Shares
$ 356.18M$ 118.72M-$ 118.18M
Diluted Average Shares
$ 356.18M$ 118.72M-$ 118.18M
Dividend Per Share
----
Total Operating Income As Reported
----
Reported Normalized Basic E P S
----
Reported Normalized Diluted E P S
----
Rent Expense Supplemental
$ 362.35K$ 362.35K$ 628.66K$ 279.19K
Total Expenses
$ 1.31M$ 1.31M$ 2.79M$ 2.07M
Net Income From Continuing And Discontinued Operation
$ -1.20M$ -1.20M$ -1.54M$ -711.80K
Normalized Income
$ -1.20M$ -1.20M$ -1.54M$ -711.80K
Interest Expense
$ 13.00---
EBIT
$ -1.21M$ -1.21M$ -1.54M$ -711.80K
EBITDA
$ -1.18M$ -1.18M$ -1.52M$ -698.74K
Currency in USD

Yubo International Biotech Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis